Skip to content

Cryo Rib Fracture Study

Comparison of Cryoablation of Intercostal Nerves to Erector Spinae Plane Catheters in Patients With Rib Fractures

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06347874
Enrollment
48
Registered
2024-04-04
Start date
2025-01-10
Completion date
2027-03-13
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rib Fractures

Brief summary

The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

Interventions

DRUGCryoablation

an injection of 1ml of 1% lidocaine per rib and ultrasound guided cryoablation of the intercostal nerves

DRUGESP Catheter

an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed intermittent bolus.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The individual doing the outcome assessments will be blinded.

Intervention model description

This is a randomized prospective controlled trial. This will be single blinded trial. The individual doing the outcome assessments will be blinded. Randomization will be 1:1.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are over 18 who have more than one ribs fractured.

Exclusion criteria

* Patients who have an exclusion to regional anesthesia. * Patients who are pregnant via self-report or pregnancy test if they take one. * Non-English speakers * Patients who have cold urticaria * Patients with bilateral fractures * Patients currently intubated

Design outcomes

Primary

MeasureTime frameDescription
Maximum pain score on POD (Post Operative Day) 77 days post procedureMaximum pain score on POD (Post Operative Day) 7
Opioid Use30 days post procedureOpioid Use measured in MMEs
Functional Pain Scores30 days post procedureFunctional Pain Scores on POD 0,1,2,3,4,5,6,7,and 30
Number of Patients using opioids at POD 3030 days post procedure, Number of Patients using opioids at POD 30
Length of hospital stay30 days post procedureLength of hospital stay measured in days:hours:minutes
Number of patients returned home by POD 3030 days post procedureNumber of patients returned home by POD 30
time to first ambulation30 days post proceduretime to first ambulation measured in days:hours:minutes
number of patients admitted to ICU30 days post procedurenumber of patients admitted to ICU
number of patients that required mechanical ventilation30 days post procedurenumber of patients that required mechanical ventilation
Pulmonary Function Testing.30 days post procedurePulmonary Function Tests include spirometry. For patients with pulmonary function testing, the test results between the two groups.

Countries

United States

Contacts

CONTACTCandace Nelson
nelso377@umn.edu
PRINCIPAL_INVESTIGATORNeil Hanson

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026